ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Abroad (travel likely)RecruitingPHASE2

Conditions

Diffuse Intrinsic Pontine Gliomas (DIPG) · Progressive DIPG · Refractory DIPG · Recurrent DIPG · H3K27-altered High Grade Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Children's Hospital Colorado, Aurora, Colorado, United States
Contact: Study coordinator (Holly Lindsay, MD) · holly.lindsay@childrenscolorado.org · 720-777-6740
Children's National Medical Center, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Eugene Hwang, MD) · ehwang@childrensnational.org · 202-476-5046
Nicklaus Children's Hospital, Miami, Florida, United States
Contact: Study coordinator (Ziad Khatib, MD) · ziad.khatib@nicklaushealth.org · 305-662-8360
Emory University/Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Contact: Study coordinator (Tobey MacDonald, MD) · tobey.macdonald@emory.edu · 404-785-1112
C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States
Contact: Study coordinator (Santhosh Upadhyaya, MBBS) · saupadhy@med.umich.edu · 734-647-8902
Contact: Study coordinator (Carl Koschmann, MD) · ckoschma@med.umich.edu · 734-647-8902
St. Louis Children's Hospital, St Louis, Missouri, United States
Contact: Study coordinator (Eric Thompson, MD) · t.eric@wustl.edu · 314-454-2810
Contact: Study coordinator (Mohamed Abdelbaki, MD) · mohameda@wustl.edu
Duke University Medical Center, Durham, North Carolina, United States
Contact: Study coordinator (Daniel Landi, MD) · daniel.landi@duke.edu · 919-684-2410
Cincinnati Children's Hospital, Cincinnati, Ohio, United States
Contact: Study coordinator (Peter de Blank, MD) · Peter.deBlank@cchmc.org · 513-517-2068
Nationwide Children's Hospital, Columbus, Ohio, United States
Contact: Study coordinator (Sara Khan, MD) · Sara.Khan@nationwidechildrens.org · 614-722-5758
Children's Hospital of Philidelphia, Philidelphia, Pennsylvania, United States
Contact: Study coordinator (MIchael J Fisher, MD) · fisherm@email.chop.edu · 215-590-5188
Texas Children's Hospital, Houston, Texas, United States
Contact: Study coordinator (Patricia Baxter, MD) · pabaxter@txch.org · 832-824-4681
Seattle Children's Hospital, Seattle, Washington, United States
Contact: Study coordinator (Erin Crotty, MD) · erin.crotty@seattlechildrens.org · 206-987-2106
Sydney Children's Hospital, Randwick, New South Wales, Australia
Contact: Study coordinator (David Ziegler, MBBS, BSc, MD, PhD, FRACP) · d.ziegler@unsw.edu.au · 612 9382 1730
Queensland Children's Hospital, South Brisbane, Queensland, Australia
Contact: Study coordinator (Tim Hassall, MBBS) · tim.hassall@health.qld.gov.au · 61 7 3068 3593
Royal Children's Hospital, Melbourne, Victoria, Australia
Contact: Study coordinator (David Eisenstat, MD) · david.eisenstat@rch.org.au
Perth Children's Hospital, Perth, Western Australia, Australia
Contact: Study coordinator (Nick Gottardo, MBChB, FRACP, PhD) · nick.gottardo@health.wa.gov.au · 618 6456 0241
The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada
Contact: Study coordinator (Eric Bouffet, MD) · eric.bouffet@sickkids.ca · 416-813-7457
Montreal Children's Hospital, Montreal, Quebec, Canada
Contact: Study coordinator (Genevieve Legault, MD) · Genevieve.Legault4@mcgill.ca · 514-412-4400
Hopp Children's Cancer Center at NCT Heidelberg (KiTZ), Heidelberg, Baden-Wurttemberg, Germany
Contact: Study coordinator (Olaf Witt, MD) · o.witt@kitz-heidelberg.de · 49 6221 42 3570
Starship Children's Hospital, Auckland, Grafton, New Zealand
Contact: Study coordinator (Sarah Hunter, MB ChB) · SHunter@adhb.govt.nz · +64 9 367 0000

Study leads

David S. Ziegler, MD, FRACP
Study Chair
Sydney Children's Hospitals Network
Sara Khan, MD, PhD, FRACP
Study Chair
Nationwide Children's Hospital
Peter de Blank, MD, MSCE
Study Chair
Children's Hospital Medical Center, Cincinnati

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma

DIPG

Abroad (travel likely)RecruitingPHASE2

Mumbai, India

xPedite: A Study to Expedite DIPG and DMG Research

Oncology · DIPG · DMG

Abroad (travel likely)Recruiting

Los Altos, United States

Study of Olutasidenib and Temozolomide in HGG

High Grade Glioma · Astrocytoma · Astrocytoma, Grade III

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Washington D.C., United States

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

High Grade Glioma · Diffuse Intrinsic Pontine Glioma · Anaplastic Astrocytoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Washington D.C., United States